MGIM
VNDA icon

M&G Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

M&G Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-91,270
Closed -$1.19K – 481
2020
Q4 		$1.19K Buy
+91,270
New +$1.1M 0.01% 299

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

M&G Investment Management's VNDA Position: Q1 2021 in Review

M&G Investment Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2021, closing a stake of 91,270 shares — an estimated $1.19K sold.

M&G Investment Management first reported a position in VNDA in Q4 2020 and held it in 1 quarter. The position peaked at $1.19K in Q4 2020. 189 funds tracked by Wall St. Rank hold VNDA as of Q1 2021.

  • M&G Investment Management reported no remaining Vanda Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • M&G Investment Management sold 91,270 Vanda Pharmaceuticals shares in Q1 2021, an estimated $1.19K.
  • M&G Investment Management first reported a position in Vanda Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • M&G Investment Management's Vanda Pharmaceuticals position peaked at $1.19K in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2021.

Based on M&G Investment Management's 13F filing for Q1 2021, filed 12 May 2021.